Revolutionizing ADC Therapies: ProEn Therapeutics Secures Investment from KOLMAR KOREA
ProEn Therapeutics, a South Korean firm specializing in oncology drug development, has secured strategic investment from KOLMAR KOREA. This investment is...
ProEn Therapeutics